Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Clinical trial NCT05098132 · RECRUITING

Trial details

NCT number: NCT05098132
Sponsor: Synthekine
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Non Small Cell Lung Cancer Untreated Advanced NSCLC 1st Line NSCLC

Start date: 2022-01-25
Primary completion: 2029-01-01
Enrollment: 364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.